ArticleAmerican journal of cancer research2020

Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells.

Sei Sai et al.PubMed ↗Full text ↗

No numbers read from the abstract.